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Abstract
A knock-in (KI) mouse model of FHM-1 expressing the R192Q missense mutation of the Cacna1a gene coding for the a1
subunit of CaV2.1 channels shows, at the level of the trigeminal ganglion, selective functional up-regulation of ATP -gated
P2X3 receptors of sensory neurons that convey nociceptive signals to the brainstem. Why P2X3 receptors are constitutively
more responsive, however, remains unclear as their membrane expression and TRPV1 nociceptor activity are the same as in
wildtype (WT) neurons. Using primary cultures of WT or KI trigeminal ganglia, we investigated whether soluble compounds
that may contribute to initiating (or maintaining) migraine attacks, such as TNFa, CGRP, and BDNF, might be responsible for
increasing P2X3 receptor responses. Exogenous application of TNFa potentiated P2X3 receptor-mediated currents of WT
but not of KI neurons, most of which expressed both the P2X3 receptor and the TNFa receptor TNFR2. However, sustained
TNFa neutralization failed to change WT or KI P2X3 receptor currents. This suggests that endogenous TNFa does not
regulate P2X3 receptor responses. Nonetheless, on cultures made from both genotypes, exogenous TNFa enhanced TRPV1
receptor-mediated currents expressed by a few neurons, suggesting transient amplification of TRPV1 nociceptor responses.
CGRP increased P2X3 receptor currents only in WT cultures, although prolonged CGRP receptor antagonism or BDNF
neutralization reduced KI currents to WT levels. Our data suggest that, in KI trigeminal ganglion cultures, constitutive up-
regulation of P2X3 receptors probably is already maximal and is apparently contributed by basal CGRP and BDNF levels,
thereby rendering these neurons more responsive to extracellular ATP.
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Introduction
Familial Hemiplegic Migraine type 1 (FHM-1) is a rare
monogenic subtype of migraine with aura that is caused by
missense mutations in the CACNA1A gene [1] that encodes the a1
subunit of neuronal voltage-gated CaV2.1(voltage-gated calcium
channel type 2.1) calcium channels [2]. Knock-in (KI) mice that
express FHM-1 R192Q-mutated CaV2.1 channels reveal gain-of-
function effects on CaV2.1 channels that can explain the increased
susceptibility to cortical spreading depression [3,4], the likely cause
of the migraine aura [5]. At the level of trigeminal sensory
ganglion neurons, which code nociceptive signals to be sent to the
brainstem trigeminal complex, the FHM-1 R192Q KI mice show
a selective gain-of-function phenotype on ATP (adenosine-5-
triphosphate)-gated P2X3 (purinergic ionotropic receptor 3)
receptors [6]. Indeed, an upward shift in the agonist concentra-
tion/response curve was demonstrated, without a change in
membrane receptor expression or of other ionotropic receptors
such as TRPV1 (transient receptor potential vanilloid 1) receptors.
Our previous experiments indicated that P2X3 receptor up-
regulation is brought about by an altered phosphorylation state of
the intracellular P2X3 receptor domains [6]. However, this does
not explain the primary cause for the observed enhancement of
P2X3 receptor responses. As P2X3 receptors in the brain and
spinal cord are almost exclusively expressed on sensory neurons
that transfer nociceptive signals to higher centers [7,8], unraveling
the primary mechanism may have significant relevance to
understanding the generation of migraine-relevant pain processes.
Since extracellular ATP levels are usually low [9], P2X3 receptors
are not continuously activated under basal conditions in WT
sensory neurons. However, constitutively up-regulated P2X3
receptors as seen in R192Q KI sensory neurons, are responsive
already after application of low doses of the selective agonist a,b-
methyleneadenosine 5-triphosphate (a,b-meATP) [6]. Hence, this
mutant P2X3 receptor phenotype may bring about a selective rise
in receptor efficacy in a migraine mouse model.
Here we investigated whether soluble factors (‘‘migraine
mediators’’; [10]), i.e. CGRP (calcitonin gene related peptide),
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BDNF (brain derived neurotrophin factor) or TNFa (tumor
necrosis factor alpha), which are relevant to triggering migraine
attacks [11,12,13,14,15,16,17], might constitutively potentiate
P2X3 receptor currents. Already a stronger release of CGRP
and TNFa was reported in R192Q KI trigeminal ganglia
[18,19,20]. It is also noteworthy that a substantial part of the
action of CGRP is produced via release of endogenous BDNF [21]
and that CGRP and BDNF may synergize to induce pain
mechanisms at trigeminal ganglion level [22,23].
The aim of the present report is to determine how ‘‘migraine
mediators’’ shape P2X3 receptor activity of cultured R192Q KI
trigeminal ganglion neurons. We applied the CGRP-selective
antagonist CGRP 8–37, or introduced an overnight deprivation of
BDNF or TNFa to dissect the effects of their endogenous
concentrations on P2X3 receptor responses. In addition, we
applied exogenous CGRP or TNFa to the cultures to investigate if
R192Q KI neurons could show the same degree of P2X3 receptor
potentiation that is usually found for WT neurons [24,25].
Results
TNFa receptor expression and activation on trigeminal
neurons
Sensory ganglia, including trigeminal ganglia, from rats were
previously shown to synthetize and release the inflammatory
mediator TNFa [18,26,27]. As recently reviewed [28,29], the
cellular effects of TNFa are mediated by two distinct receptor
classes (TNFR1 and TNFR2).While TNFR1 is ubiquitously
expressed and is canonically considered to be a pro-apoptotic
signal in cell death pathways, TNFR2 expression is restricted to
immune cells like microglia and macrophages, neurons and
oligodendrocytes. In view of previous reports that neuroinflamma-
tion might be contributory to sensitize neurons in migraine attacks
[9,18,30,31], we first investigated whether mouse trigeminal
ganglion neurons could respond to TNFa as evidenced by their
expression of the TNFa receptor TNFR2 ([32]; Fig. 1A, B). The
large majority of trigeminal ganglion neurons in both WT and KI
cultures were also immunopositive for P2X3 antibody (Fig. 1A, B).
This observation suggests that mouse trigeminal ganglion neurons
could be a target for TNFa, an issue investigated by whole-cell
patch clamping of neurons in response to pulses of P2X3 receptor
agonist a,b-meATP (Fig. 1C). Fast inward currents elicited by a,b-
meATP (10 mM; 2 s) on WT neurons were enhanced by a 4-hour
pretreatment with TNFa (50 ng/mL; Fig. 1 C,D). A similar
increase in current amplitude was observed with 100 ng/mL
TNFa (406649 pA versus 282635 pA of untreated control,
n = 10 and n = 14, respectively; p = 0.04). Notably, P2X3 receptor
currents of KI neurons, which are constitutively larger than of WT
ones (Fig. 1D and [6]), were not further potentiated by 50 ng/mL
TNFa pretreatment (Fig. 1 C, D). Even using 100 ng/mL TNFa,
the average peak amplitude of treated KI neurons was
389648 pA (n = 10); a value not significantly different from
untreated control (438670 pA, n = 11). These data are in
accordance with our previous results [18] that indicated how
experimentally-evoked increase in TNFa gene expression was
followed by facilitation of P2X3 receptors in WT neurons only.
Former studies have indicated that exogenous TNFa can
increase neuronal Ca2+ influx via augmented activity of TRPV1
receptors on rat sensory neurons [33,34]. We investigated whether
TNFa application to mouse trigeminal ganglion cultures could
also potentiate membrane TRPV1 receptor currents that were
activated by pulses of capsaicin (1 mM; 2 s), as reported for rat
neurons [35,36]. Fig. 2A shows sample traces of enhancement of
capsaicin-evoked currents by prior application of TNFa on small
diameter neurons, which typically express TRPV1 receptors
[6,37]. It is noteworthy that, on average, WT and KI TRPV1
currents had similar amplitudes under control conditions (Fig. 2
B), indicating that there was no phenotype-dependent TRPV1
regulation. While TRPV1 receptors on WT neurons required a
large dose of TNFa to exhibit potentiation, responses of KI
neurons required only half of that dose (Fig. 2B). These results,
therefore, suggest that TRPV1 receptors of KI neurons were more
susceptible to transient application of TNFa.
We next enquired whether basal, strong responses of P2X3
receptors of KI neurons might be due to a constitutively high
release of endogenous TNFa, which would prevent further
increment of P2X3 receptor-mediated responses. To investigate
this, we caused TNFa deprivation by overnight administering a
TNFa neutralizing antibody, and, after washout, recorded
responses to a,b-meATP. A similar deprivation protocol had been
used to investigate the role of endogenous NGF, another potent
algogen on trigeminal ganglion neurons [38]. The TNFa
deprivation protocol did not change P2X3 receptor responses in
either WT or KI neurons (Fig. 3A, B). The simplest interpretation
of these results is that there was insufficient background release of
endogenous TNFa to modulate P2X3 receptors under basal
conditions. This notion prompted us to investigate other
mechanisms that might be responsible for the P2X3 receptor
enhancement that was observed in R192Q KI neurons.
Effect of CGRP antagonism or BDNF deprivation on P2X3
receptors
Next, we investigated the action of the neuropeptide CGRP, an
important migraine mediator that is known to evoke a sustained
facilitation of P2X3 receptors via complex intracellular signaling
pathways in WT trigeminal ganglia [19,24]. A role of CGRP in KI
trigeminal ganglia, however, is less obvious. Previously, R192Q KI
ganglia were shown to contain less CGRP than WT [39], an
observation that may be accounted for by a stronger release of
CGRP [19]. Fig. 4A, B shows that CGRP (1 mM, 2 h; [24])
significantly enhanced WT P2X3 responses without affecting those
of KI. One may postulate that potentiation of P2X3 receptors
could be already at the maximal level, because of raised
endogenous CGRP, and, therefore, these receptors had become
unresponsive to further CGRP administration. Measuring CGRP
concentrations in the bulk culture medium or in culture extracts
may not be suitable for providing the actual concentration at
neuronal level because of large dilution and/or degradation the
peptide. Therefore, we investigated the influence of constitutive
release of CGRP on P2X3 receptors, by overnight application of
the specific CGRP receptor antagonist CGRP8–37 [24,40]. Fig. 4C,
D illustrates that CGRP8–37 pretreatment did not change the
amplitude of P2X3 receptor currents of WT neurons, but instead
returned P2X3 responses of KI neurons to the same level of WT
neurons. These data point to a significant role of endogenous
CGRP in facilitating P2X3 receptor currents, specifically of KI
neurons.
Previous studies [21] have demonstrated that a substantial
component of the action by CGRP on trigeminal ganglion
neurons is caused indirectly via release of BDNF, a known algogen
[13,21,41,42,]. We queried whether the basal potentiation of
P2X3 receptors of KI neurons was also due to the combined
action of CGRP and BDNF. To this end, first we confirmed that
BDNF significantly (p = 0.019) potentiated WT P2X3 receptors as
the average peak current amplitude rose from 281631 pA (n = 15)
to 464661 pA (n = 18) in support of our earlier reports which
have shown increased P2X3 mRNA upon BDNF treatment [21].
Second, we assessed the BDNF immunoreactivity of trigeminal
Trigeminal Neuron Sensitization
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ganglion neurons of WT or KI cultures (Fig. 5A, B). The average
number of BDNF-positive neurons (identified by b-tubulin III
immunopositive signals; Fig. 5A, red pseudocolor) was significantly
higher in KI cultures compared to WT cultures. In support of this
finding, overnight treatment with a BDNF neutralizing antibody
[21] showed no change in P2X3 receptor currents of WT neurons,
whereas the current amplitude of KI neurons was significantly
decreased (Fig. 5C, D).
Discussion
The present study proposes that basal release of CGRP and
BDNF contributes to the observed potentiation of P2X3 receptors
of FHM-1 R192Q KI trigeminal neurons. It seems probable that
facilitated release of CGRP and BDNF, at least in part, was
dependent on the stronger Ca2+ influx into R192Q KI neurons
[6], which is in line with other gain-of-function effects of the
R192Q-mutated CaV2.1 channels as reported for brainstem [43]
and cerebral cortex [4] excitatory synapses.
Since CGRP is considered an important trigger of migraine
attacks, current clinical studies have focused on the use of CGRP
antagonists as a possible treatment [16,17,44,45]. The involve-
ment of CGRP mechanisms in the pathophysiology of FHM has
been debated, for instance by reports showing lack of hypersen-
sitivity of FHM patients to CGRP infusion [46,47]. However, our
findings argue that, in trigeminal neurons expressing the R192Q
mutation in CaV2.1 channels (as in R192Q KI mice), potentiation
of P2X3 receptors was no longer possible by exogenous CGRP as
this effect had reached saturation. A role of endogenous CGRP is
also supported by the observation that overnight application of a
selective CGRP antagonist could return P2X3 response level in KI
neurons to that of WT neurons. Hence, we propose that
trigeminal neurons expressing the R192Q FHM-1 mutation are
already enhanced in their P2X3 receptor sensitivity by
Figure 1. Effect of TNFa on P2X3 receptor activity and co-expression of its TNFR2 receptors. A, Examples of TNFR2 and P2X3 co-
exexpression in (wildtype) WT and R192Q (knockin) KI neurons. Left panel shows P2X3 expression (green), and right panel shows TNFR2 staining (red).
B, Histograms quantifying % of cells co-expressing TNFR2 and P2X3: both WT and KI cultures show similar TNFR2 and P2X3 co-expression. N = 3
independent experiments (6 mice). C, Representative traces of currents induced by application of a,b-meATP (10 mM, 2 s) to WT or R192Q KI neurons
in control conditions or after 4 h TNFa application. D, Histograms show average peak amplitudes of P2X3 receptor-mediated currents: WT control
(open bar), n = 30; WT TNFa (stippled bar), n = 38; KI control (grey bar), n = 34; KI TNFa (stippled gray bar), n = 34; ** = p,0.006; * = p,0.05.
doi:10.1371/journal.pone.0060677.g001
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endogenously elevated CGRP levels, and, therefore, cannot be
further potentiated by the exogenously administered CGRP
peptide.
Blocking the action of endogenous CGRP or BDNF (an
intermediate mediator of the effect by CGRP on P2X3 receptors;
[21]) led to significant reduction of P2X3 currents to WT levels. In
WT neurons, 50% of the potentiation of P2X3 receptors by
CGRP is attributed to release of endogenous BDNF [21]. In
R192Q KI trigeminal ganglia, the role of BDNF in P2X3 receptor
response likely is relevant as the majority of P2X3-positive neurons
express this neurotrophin. In view of the synergy of BDNF and
glutamate (the excitatory transmitter of trigeminal ganglion
neurons) in synaptic transmission [48,49], if enhanced release of
BDNF occurs in the brain as well, it seems plausible that this
neurotrophin contributes to the dysregulated neuronal excitability
caused by overactive glutamatergic synapses of R192Q-mutated
cortical neurons [4].
Clinical and experimental studies have proposed that a
neuroinflammatory state of meninges, enriched with inflammatory
cells releasing pain mediators like TNFa [50], known to play an
important role in chronic pain [51], might contribute to migraine
attacks [30,31]. We recently provided first evidence for a
proinflammatory profile, both in vivo and in vitro, in R192Q KI
trigeminal ganglia, which suggests that neuroinflammation may
occur also in this migraine mouse model [26]. Here, we could
show that, in WT or KI trigeminal ganglia, the large majority of
neurons co-express P2X3 and TNFa receptors rendering them
potentially sensitive to TNFa-mediated inflammation and related
pain signaling. Nevertheless, the phenomenon of exogenous TNFa
enhanced P2X3 responses exclusively in WT neurons and not in
Figure 2. Sensitization of TRPV1 receptors by TNFa. A, Representative traces of currents induced by application of capsaicin (1 mM, 2 s) to WT
or R192Q KI neurons in control conditions or after 4 h application of TNFa. B, Histograms show average peak amplitudes of TRPV1-mediated currents
(WT control, n = 29; WT TNFa 50 ng/mL n=19, WT TNFa 100 ng/mL, n = 10; KI control, n = 26; KI TNFa 50 ng/mL, n = 23,, KI TNFa 100 ng/mL n= 9);
* = p,0.05, ** = p,0.002, *** = p,0.001.
doi:10.1371/journal.pone.0060677.g002
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KI cells, is analogous to the one seen with exogenous CGRP and is
probably caused by P2X3 receptor saturation. Lack of exogenous
TNFa effect on R192Q KI neurons was not attributable to rapid
degradation or unresponsive receptors because the same substance
readily facilitated TRPV1 receptors. The latter observation is in
accordance with previous reports with WT sensory cells [35,36]
and it was obtained after a smaller dose of TNFa for KI neurons.
Future in vivo experiments are necessary to assess whether the
TNFa-evoked potentiation of TRPV1 currents plays a major
functional role in processing nociceptive signals as these receptors
are expressed by a minority of neurons (usually half of the small
diameter cells; [20,37] and, under basal conditions, they do not
functionally differ between WT and KI neurons [6].
Unlike the observations with CGRP and BDNF, an overnight
deprivation of TNFa was not followed by down-regulation of
P2X3 receptors in WT or KI neurons, which may be due to the
low level of endogenous TNFa [18]. Furthermore, while previous
studies have indicated a close, positive interaction between TNFa
and CGRP [52], this effect was presumably weak in trigeminal
ganglion cultures as the functional outcome of overnight
deprivation of each substance was different. One attractive
hypothesis that deserves further attention is that, in R192Q KI
trigeminal ganglia, enhanced endogenous CGRP and BDNF
levels contribute to up-regulate basal P2X3 receptor function of
most sensory neurons, preparing them to respond more efficiently
to extracellular ATP, a putative mediator of migraine attacks [53].
On the other hand, a surge in extracellular TNFa might serve to
increase TRPV1 receptor activity and, thus, perhaps amplify
peripheral nociceptive transduction which is thought to be
important for migraine pain [54].
Materials and Methods
Culture of mouse trigeminal ganglia
For the experiments, R192Q KI and WT mouse littermates
were used. Our colony of mice is bred locally, after an initial
transfer of mice from Leiden University Medical Centre [3]. Mice
were maintained in accordance with the Italian Animal Welfare
Act. The experimental protocols were approved by the SISSA
ethical committee. Genotyping was performed by polymerase
chain reaction (PCR), as previously reported [3]. Trigeminal
ganglion cultures were obtained from 2-week-old animals and
were used 24 h after plating [6,21]. For all experiments, WT and
KI cultures were used in parallel at the same time to allow for
direct comparison of experimental data.
Immunostaining
Primary cultures obtained from two ganglia were plated on 2–3
coverslips for parallel analysis of immunoreactive signals. Cultures
were fixed with 4% PFA and processed for immunofluorescence
microscopy [6,21]. The following antibodies, whose selectivity has
been validated previously [6,21], were used: anti-P2X3 (1:300;
Neuromics, Edina, MN, USA), anti-TNFR2 (1:50, Santacruz
Biotechnology, Heildelberg, Germany), anti-b-tubulin III (1:1000;
Sigma, Milan, Italy); anti-BDNF (1:50; Sigma). Antibodies were
incubated for 2 h in phosphate saline buffer plus 5% bovine serum
albumin and 0.1% Tween20. Secondary antibodies anti-rabbit,
anti- conjugated with AlexaFluor488 or AlexaFluor594 were
purchased from Invitrogen (1:500; S. Giuliano Milanese, Italy).
Stainings with secondary antibodies only were performed as
control experiments and did not give any signal. Images from
cultures were visualized with a Zeiss Axioskop fluorescence
microscope (Zeiss, Zurich, Switzerland) and analyzed with
Figure 3. Ambient TNFa may not contribute to basal upregulation of KI P2X3 receptor function. A, Representative traces of currents
induced by application of a,b-meATP (10 mM, 2 s) to WT or R192Q KI neurons in control conditions or after overnight application of anti-TNFa
antibody. B, Histograms show average peak amplitudes of P2X3 receptor-mediated currents (WT control, n = 23; WT anti-TNFa, n = 14; KI control,
n = 34; KI anti-TNFa, n = 20). * = p,0.05.
doi:10.1371/journal.pone.0060677.g003
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MetaMorph software (Molecular Devices, Downingtown, PA,
USA) for cell counting. The number of neurons expressing
TNFR2 was calculated as a percent value of the total number of
neurons expressing P2X3 receptors. BDNF-immunoreactive
neurons were expressed as percent value of b-tubulin-positive
neurons. Data are the mean of at least three independent
experiments.
Electrophysiology
After 1 day in culture, trigeminal neurons were superfused
continuously (2 mL/min) with physiological solution containing
(in mM): 152 NaCl, 5 KCl, 1 MgCl2, 2 CaCl2, 10 glucose, and 10
HEPES (pH adjusted to 7.4 with NaOH). Cells were patch-
clamped in the whole-cell configuration using pipettes with a
resistance of 3–4 MV when filled with the following solution (in
mM): 140 KCl, 0.5 CaCl2, 2 MgCl2, 2 Mg2ATP3, 2 GTP, 10
HEPES, and 10 EGTA (pH adjusted to 7.2 with KOH).
Recording of P2X3 receptor-mediated currents was performed
mostly on small and medium size neurons with capacitance less
than 20 pF (ranging from 8 to 23 pF), the vast majority of which
expresses these receptors [35]. For recording capsaicin-induced
currents, data were obtained from small diameter neurons
(capacity,15 pF). Cells were held at 265 mV after correcting
for the liquid junction potential. Currents were filtered at 1 kHz
and acquired by means of a DigiData 1200 Interface and pClamp
8.2 software (Molecular Devices, Sunnyvale, CA, USA). To obtain
stable and reproducible P2X3 receptor currents, its synthetic
agonist a,b-methylene-adenosine-59-triphosphate (a,b-meATP;
10 mM; Sigma) was applied (for 2 s) using a fast superfusion
system (Rapid Solution Changer RSC-200; BioLogic Science
Figure 4. Role of CGRP in KI P2X3 currents. A, Representative traces of currents induced by application of a,b-meATP (10 mM, 2 s) to WT or
R192Q KI neurons in control conditions or after 2 h CGRP (1 mM) application. B, Histograms show average peak amplitudes of P2X3 receptor-
mediated currents (WT control, n = 11; WT CGRP, n = 9; KI control, n = 17; KI CGRP, n = 18), * = p,0.05. C, Representative examples of currents induced
by application of a,b-meATP (10 mM, 2 s) to WT or R192Q KI neurons in control conditions or after overnight application of the CGRP antagonist
CGRP8–37 (1 mM). D, Histograms show average peak amplitudes of P2X3 receptor-mediated currents (WT control, n = 23; WT CGRP8–37, n = 23; KI
control, n = 29; KI CGRP8–37, n = 30); * = p,0.05.
doi:10.1371/journal.pone.0060677.g004
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Instruments, Claix, France). In accordance with our previous
studies [6,9,18], this concentration of a,b-meATP was selected as
it evokes near maximal responses that were suitable to test any
depression caused by prolonged deprivation of endogeneous
factors. In line with previous reports with the same type of WT
or KI neurons [6,20], capsaicin (Sigma) was applied at the
concentration of 1 mM (for 2 s) to evoke reproducible inward
currents. In all experiments employing overnight or prolonged
treatment of culture, the culture medium was washed out with
physiological solution at the end of the incubation period and
patch clamp recording was commenced within 10 min. For
deprivation experiments the following treatments were applied for
24 h starting at the time of plating the cultures: anti-BDNF
(neutralizing antibody; final dose = 10 mg/mL; Promega, Madi-
son, WI, USA), or anti-TNF-a (neutralizing antibody; 1:200 from
5 mg/mL stock; Abcam, Cambridge, UK). The neutralizing
TNFa antibody and the BDNF antibodies were validated with
Western immunoblotting for their effectiveness [18,21]. The
CGRP antagonist peptide CGRP8–37 (Sigma) was applied
overnight at 1 mM concentration [24]. TNFa (R&D microsystems,
Abingdon, UK) was applied at the dose of 50 or 100 ng/mL as
previously performed for sensory ganglia [41,52]. The timing of
application of TNFa (4 h) was chosen based on the observation
that its endogenous production and activity on trigeminal ganglion
neurons peak 4 h after experimental inflammation [18]. CGRP
(1 mM; Sigma) or BDNF (10 ng/mL; Sigma) were applied for 2 h
as was done in a previous study [21,24].
Statistics
Data are expressed as mean 6 SEM (standard error of the
mean), where n indicates the number of independent experiments
or the number of investigated cells. Statistical analysis was
Figure 5. Number of BDNF expressing neurons in KI culture and effect of BDNF deprivation. A, Examples of b-tubulin positive neurons
expressing BDNF in WT or KI cultures. Left panel (green) shows BDNF expression and right panel (red) shows b-tubulin staining of the same neurons.
B, Histograms quantifying % of neurons expressing BDNF: KI cultures showed significantly higher number of BDNF positive neurons. N = 4
independent experiments (8 mice), p,0.05. C, Representative traces of currents induced by application of a,b-meATP (10 mM, 2 s) to WT or R192Q KI
neurons in control conditions or after overnight application of anti-BDNF antibody. D, Histograms show average peak amplitudes of P2X3 receptor-
mediated currents (WT control, n = 9; WT anti-BDNF, n = 10; KI control, n = 32; KI anti-BDNF, n = 38); * = p,0.05.
doi:10.1371/journal.pone.0060677.g005
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performed using the Student’s t test or the Mann–Whitney rank
sum test after the software-directed choice of parametric or
nonparametric data, respectively (Sigma Plot and Sigma Stat,
Chicago, IL,USA). A p value of #0.05 was accepted as indicative
of a statistically significant difference.
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